Speaker illustration

Doctor Michaela Meyer

Bayer AG, Wuppertal (Germany)

Leveraging translational approaches for accelerated clinical development of vericiguat

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Chronic heart failure e-posters

Thumbnail

A concentration-QTc analysis of vericiguat

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Chronic heart failure e-posters

Thumbnail

Population pharmacokinetics and pharmacodynamics of vericiguat in heart failure patients with reduced ejection fraction

Event: Heart Failure 2019 - 6th World Congress on Acute Heart Failure

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Session: Chronic Heart Failure – Pathophysiology and Mechanisms

Thumbnail

This platform is supported by

logo Novo Nordisk